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Background/Introduction
True node-negative small sized non-small cell lung can-
cers are optimal candidates for sublobar resection without
systematic lymph node dissection.
Aims/Objectives
The purpose of this study is to identify the predictive
factors of true node-negative clinical stage IA non-small
cell lung cancer.
Method
A multicenter database of patients with completely
resected clinical stage IA lung adenocarcinoma (n = 502)
or squamous cell carcinoma (n = 100) was retrospectively
analyzed. The relationship between lymph node status
and preoperative factors such as tumor size on HRCT
and maximum standardized uptake value (SUVmax) on
FDG-PET/CT were examined.
Results
Multivariate analyses revealed that solid tumor size on
HRCT (Odds ratio (OR), 1.42; p < 0.001) or SUVmax on
FDG-PET/CT (OR, 1.04; p = 0.049) was identified as an
independent predictor of lymph node metastasis in
patients with lung adenocarcinoma. The predictive criteria
of node-negative lung adenocarcinoma were solid tumor
size <0.8 cm or SUVmax <1.5. Among patients who met
the node-negative criteria, recurrence-free survival at
5 years was not significantly different between those who
underwent lobectomy (96.0%) and those who underwent
sublobar resection (97.2%). In patients with squamous cell
carcinoma of the lung, no independent predictive factors
for lymph node metastasis were identified in univariate or
multivariate analysis.
Discussion/Conclusion
Either solid tumor size on HRCT or SUVmax on
FDG-PET/CT was a significant independent predictor of
nodal status in clinical stage IA lung adenocarcinoma. The
node-negative criteria of solid tumor size <0.8 cm or
SUVmax <1.5 are helpful for choosing candidates for sub-
lobar resection without systematic lymphadenectomy. In
patients with clinical stage IA lung squamous cell carci-
noma, systematic lymphadenectomy is advisable.
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